Finally seeing a tail off in the number of names hitting the list, as earnings season begins to wine down.This is not to say that a few companies did not jump after reporting earnings. However, other names worth mentioning include LVB, which gained after receiving another offer for the firm, and GALT, which was granted fast-track status for one of its pipeline drugs.
No comments:
Post a Comment